Stock GYRE GYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Gyre Therapeutics, Inc.

Equities

GYRE

US4037831033

Biotechnology & Medical Research

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
15.69 USD +5.87% Intraday chart for Gyre Therapeutics, Inc. +13.20% -38.93%
Apr. 03 Gyre Therapeutics Insider Sold Shares Worth $323,000, According to a Recent SEC Filing MT
Mar. 26 Gyre Therapeutics Swings to Fiscal 2023 Net Loss, Revenue Rises MT

Valuation

Fiscal Period: December 2023
Capitalization 1 -
Enterprise Value (EV) 1 -
P/E ratio -18.2 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -
FCF Yield -
Price to Book -124 x
Nbr of stocks (in thousands) -
Reference price 2 25.69
Announcement Date 3/27/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023
Net sales 1 102.3 113.4
EBITDA 1 10.33 20.33
EBIT 1 9.203 19.21
Operating Margin 9% 16.94%
Earnings before Tax (EBT) 1 9.412 -76.96
Net income 1 2.302 -92.93
Net margin 2.25% -81.92%
EPS 2 0.0300 -1.412
Free Cash Flow - 20.67
FCF margin - 18.22%
FCF Conversion (EBITDA) - 101.69%
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 3/27/24 3/27/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023
Net Debt 1 - -
Net Cash position 1 24.6 33.1
Leverage (Debt/EBITDA) - -
Free Cash Flow - 20.7
ROE (net income / shareholders' equity) - -113%
ROA (Net income/ Total Assets) - 11.9%
Assets 1 - -778.9
Book Value Per Share 2 0.6700 -0.2100
Cash Flow per Share 2 0.4000 0.4400
Capex 1 4.99 8.52
Capex / Sales 4.87% 7.51%
Announcement Date 3/27/24 3/27/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GYRE THERAPEUTICS, INC. Stock Gyre Therapeutics, Inc.
-38.93% 1.34B
MODERNA, INC. Stock Moderna, Inc.
+23.37% 46.71B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.8B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.94% 41.52B
CELLTRION, INC. Stock Celltrion, Inc.
-5.86% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.29% 25.78B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.92% 19.26B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.20% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.67% 12.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.23% 11.98B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. GYRE Stock
  4. Financials Gyre Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW